These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: The estrogenicity of delta-9-tetrahydrocannabinol (THC): THC neither blocks nor induces ovum implantation, nor does it effect uterine growth.
    Author: Virgo BB.
    Journal: Res Commun Chem Pathol Pharmacol; 1979 Jul; 25(1):65-77. PubMed ID: 451360.
    Abstract:
    The estrogenicity of THC was assessed in three estrogen-sensitive systems. The drug did not block implantation when injected (s.c.) on Day 0 of pregnancy: on Day 6, 95% (3 mg/kg) and 86% (12 mg/kg) of the mice had embryos as did 96% (P greater than 0.1) of the controls; implantation occurred in only 9% (P less than 0.005) of mice treated similarly with estradiol (E2; 0.15 mg/kg). Nor did THC induce implantation: pregnant mice were ovariectomized on Day 1, treated daily with progesterone (2 mg, s.c.) and injected (i.p.) with THC on Day 3: at mg THC/kg 39% had embryos, as did 41% of those at 6 mg/kg; these rates do not differ (P greater than 0.99) from that of the controls (38%); in contrast, ova implanted in 75% (P less than 0.025) of E2-treated mice (4.0 microgram/kg). The average number of implanting ova was the same in all groups in both experiments. THC did not cause uterine hypertrophy: ovariectomized mice were injected (s.c.) for 14 days with THC (3 or 6 mg/kg) or E2(2 microgram/kg): the uterine weight, total uterine protein and total uterine glycogen of the ovariectomized controls was 24 +/- 2 mg, 3 +/- 0.3 mg and 11 +/- 3 mg respectively and the values for the THC-treated mice were not different (P greater than 0.05); in contrast, E2 increased (P less than 0.01) uterine weight to 139 +/- 9 mg, uterine protein to 5 +/- 0.6 mg and uterine glycogen to 62 +/- 8 mg. It is concluded that THC is not estrogenic.
    [Abstract] [Full Text] [Related] [New Search]